Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
240.34
204.92
192.57
161.71
141.15
120.86
108.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
240.34
204.92
192.57
161.71
141.15
120.86
108.19
Raw Material Cost
41.19
33.51
38.14
28.09
18.94
15.54
15.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.57
7.67
6.53
6.72
6.72
6.76
7.06
Selling and Distribution Expenses
82.13
88.22
62.74
63.37
55.59
50.33
38.90
Other Expenses
7.88
4.07
3.47
3.42
2.51
3.96
1.68
Total Expenditure (Excl Depreciation)
218.66
170.12
142.08
132.34
106.31
112.23
78.24
Operating Profit (PBDIT) excl Other Income
21.7
34.8
50.5
29.4
34.8
8.6
29.900000000000002
Other Income
6.36
3.92
1.56
2.85
2.97
3.71
3.06
Operating Profit (PBDIT)
28.13
38.80
52.56
32.70
38.31
12.84
33.08
Interest
16.57
7.67
6.53
6.72
6.72
6.76
7.06
Exceptional Items
-1.23
-10.69
-0.43
0.42
-0.18
-0.10
-0.50
Gross Profit (PBDT)
199.14
171.41
154.43
133.62
122.21
105.31
92.72
Depreciation
0.10
0.08
0.50
0.49
0.49
0.51
0.06
Profit Before Tax
10.23
20.36
45.09
25.91
30.92
5.47
25.45
Tax
2.45
0.59
22.06
-364.99
2.73
0.41
2.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7.78
19.78
23.04
390.89
28.19
5.06
23.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7.78
19.78
23.04
390.89
28.19
5.06
23.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7.78
19.78
23.04
390.89
28.19
5.06
23.33
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
604.08
583.13
648.02
607.22
276.43
237.29
222.36
Earnings per share (EPS)
0.05
0.12
0.14
2.43
0.17
0.03
0.15
Diluted Earnings per share
0.05
0.12
0.14
2.43
0.17
0.03
0.15
Operating Profit Margin (Excl OI)
9.02%
16.98%
26.22%
18.16%
24.69%
7.13%
27.68%
Gross Profit Margin
4.3%
9.98%
23.68%
16.33%
22.25%
4.95%
23.58%
PAT Margin
3.24%
9.65%
11.96%
241.73%
19.97%
4.19%
21.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 17.28% vs 6.39% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -60.61% vs -13.91% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -37.54% vs -31.57% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 115.58% vs 18.46% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of TG Therapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
240.34
149.39
90.95
60.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
240.34
149.39
90.95
60.88%
Raw Material Cost
41.19
24.18
17.01
70.35%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
16.57
0.00
16.57
Selling and Distribution Expenses
82.13
49.32
32.81
66.52%
Other Expenses
7.88
0.27
7.61
2,818.52%
Total Expenditure (Excl Depreciation)
218.66
76.16
142.50
187.11%
Operating Profit (PBDIT) excl Other Income
21.67
73.23
-51.56
-70.41%
Other Income
6.36
6.25
0.11
1.76%
Operating Profit (PBDIT)
28.13
89.33
-61.20
-68.51%
Interest
16.57
0.00
16.57
Exceptional Items
-1.23
4.75
-5.98
-125.89%
Gross Profit (PBDT)
199.14
125.21
73.93
59.04%
Depreciation
0.10
9.85
-9.75
-98.98%
Profit Before Tax
10.23
84.23
-74.00
-87.85%
Tax
2.45
20.50
-18.05
-88.05%
Provisions and contingencies
0
0
0.00
Profit After Tax
7.78
63.73
-55.95
-87.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7.78
63.73
-55.95
-87.79%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7.78
63.73
-55.95
-87.79%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
604.08
1,012.70
-408.62
-40.35%
Earnings per share (EPS)
0.05
0.50
-0.45
-90.00%
Diluted Earnings per share
0.05
0.50
-0.45
-90.00%
Operating Profit Margin (Excl OI)
9.02%
49.02%
0.00
-40.00%
Gross Profit Margin
4.30%
62.98%
0.00
-58.68%
PAT Margin
3.24%
42.66%
0.00
-39.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 24.03 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 17.28% vs 6.39% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 70.30% vs 91.97% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.78 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -60.61% vs -13.91% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -72.34% vs 308.70% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.18 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -37.54% vs -31.57% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -38.24% vs 296.63% in Jun 2025
Quarterly - Interest
Interest 1.66 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 115.58% vs 18.46% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 147.76% vs 67.50% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.02%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
